Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-003090
Filing Date
2025-04-07
Accepted
2025-04-07 21:41:37
Documents
2
Period of Report
2025-04-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4360
2 ex24-1.htm EX-24.1 12290
  Complete submission text file 0001641172-25-003090.txt   18175
Mailing Address 1455 ADAMS DRIVE, SUITE 2050 MENLO BUSINESS PARK MENLO PARK CA 94025
Business Address
Cundy Kenneth C (Reporting) CIK: 0001322959 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40388 | Film No.: 25820003

Mailing Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734
Business Address C/O ANEBULO PHARMACEUTICALS, INC. 1017 RANCH ROAD 620 SOUTH, SUITE 107 LAKEWAY TX 78734 737 203 5270
Anebulo Pharmaceuticals, Inc. (Issuer) CIK: 0001815974 (see all company filings)

EIN.: 851170950 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)